Regulation & Compliance

Inspira Technologies announces a landmark deal to acquire a liquid biopsy firm, securing a $15M investment at a $180M valuation to enter the cancer market.

Amid regulatory hurdles and a shifting housing market, AM Best analysts will offer key insights for the U.S. title insurance industry's future.

The acclaimed '1/6' graphic novel series releases its finale, a resistance-driven story that eerily anticipated authoritarian moves in a post-Jan. 6 world.

Latin America's largest investment bank completes its takeover of M.Y. Safra Bank, gaining a coveted US banking license to serve global clients.

With a fresh funding series, Clipto.AI is pioneering a privacy-first future where powerful AI processes your sensitive content directly on your device.

Opus Fund Services launches SmartWire, an AI-driven platform designed to automate payments and secure fund managers against fraud and operational risks.

A recognized expert in veterans' law and architect of key VA reforms takes the helm at DAV's DC headquarters, signaling a new era of focused advocacy.

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

With a key presentation looming, Star Therapeutics aims to showcase its universal hemostatic therapy, VGA039, for von Willebrand disease.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.

With pivotal Phase 2 data for its non-invasive skin cancer patch due in Q1, Medicus Pharma is advancing a diverse pipeline fueled by AI and strategic acquisitions.

Gyre Therapeutics secures a pivotal conditional approval pathway in China for its novel liver fibrosis drug, offering hope for millions of hepatitis B patients.

A new drug could redefine life for polycythemia vera patients, replacing frequent, burdensome blood draws with a simple weekly self-injection.

With Clay Van Doren as new CEO, Avenga signals a major push for global leadership in AI and digital engineering, leveraging his Atos experience.

Health Canada has approved JERAYGO, the first new hypertension drug class in 30 years, offering a lifeline to patients with hard-to-treat high blood pressure.

As Bank of Marin prepares its Q4 earnings call, investors are watching how its 2025 strategic shifts will fare against Northern California's mixed economy.

A new study finds traditional banks reject 93% of emergency loan seekers, pushing millions toward predatory lenders with 400%+ APR. Is fintech the answer?

Entertainment giant Banijay divests its majority stake in bet-at-home to fund a landmark merger with Tipico, reshaping its gaming strategy and the market.

A major study reveals dropping MMR vaccination rates and a surge in measles, but identifies a key window for pediatricians to prevent missed immunizations.

Amid a crucial patent appeal and a competitive market, Scilex Holding hires renowned trial lawyer Marc Kasowitz, signaling an aggressive new legal strategy.